In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Alexandra Twin has 15+ years of experience as an editor and writer, covering financial news for public and private companies. Samantha (Sam) Silberstein, CFP®, CSLP®, EA, is an experienced financial ...
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, ...
Condé Nast Traveler readers believe this major US city is the end-all-be-all for shopping destinations in the country.